Evidence map›Paper›PMID 37781188›Full record

ReviewFrontiers in oncology2023

The role of the oxytocin system in the resilience of patients with breast cancer.

Shaochun Liu, Runze Huang, Anlong Li, Sheng Yu, Senbang Yao, Jian Xu, Lingxue Tang, Wen Li, Chen Gan, Huaidong Cheng

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shaochun LiuDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Runze HuangDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Anlong LiDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Sheng YuDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Senbang YaoDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Jian XuDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Lingxue TangDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Wen LiDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Chen GanDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Huaidong ChengDepartment of Oncology, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.
Second Hospital of Anhui Medical University · CNAnhui Medical University · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a grave traumatic experience that can profoundly compromise patients' psychological resilience, impacting their overall quality of life. The oxytocin system represents one of the essential neurobiological bases of psychological resilience and plays a critical role in regulating resilience in response to social or traumatic events during adulthood. Oxytocin, through its direct interaction with peripheral or central oxytocin receptors, has been found to have a significant impact on regulating social behavior. However, the precise mechanism by which the activation of peripheral oxytocin receptors leads to improved social is still not completely comprehended and requires additional research. Its activation can modulate psychological resilience by influencing estrogen and its receptors, the hypothalamic-pituitary-adrenal axis, thyroid function, 5-hydroxytryptamine metabolism levels, and arginine pressure release in breast cancer patients. Various interventions, including psychotherapy and behavioral measures, have been employed to improve the psychological resilience of breast cancer patients. The potential effectiveness of such interventions may be underpinned by their ability to modulate oxytocin release levels. This review provides an overview of the oxytocin system and resilience in breast cancer patients and identifies possible future research directions and interventions.

Indexed as

behavioral interventionsbreast canceroxytocin systempsychotherapyresilience

Identifiers

PMID37781188
PMCPMC10534028
OpenAlexW4386699880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.